ALBANY, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CURE GM1 INCORPORATED, founded in 2014, is a small nonprofit in the Medical Research sector that reported $534K in total revenue in fiscal year 2023. Expenses of $689K exceeded revenue, resulting in a 29% operating deficit.
THE PURPOSE OF THE ORGANIZATION IS TO RAISE FUNDS FOR MEDICAL RESEARCH FOR A RARE DISEASE CALLED GM1 GANGLIOSIDOSIS THAT HAS NO CURE OR TREATMENT OTHER THAN COMFORT MEASURES AND SYMPTOM MANAGEMENT. PROMISING RESEARCH EXISTS, BUT LACKS FUNDING. THE ORGANIZATION HOPES TO UNIT FAMILIES OF THOSE WHO SUFFER FROM THIS DISEASE AND THEIR SUPPORTERS BY FUNDRAISING FOR A CURE.
MANY GM1 CAREGIVERS PARTICIPATED IN THE STUDY, "HUMANISTIC BURDEN OF NEURODEGENERATIVE LYSOSOMAL DISORDERS IN THE US: INSIGHTS FROM CAREGIVERS OF PATIENTS LIVING WITH GM1 AND GM2 GANGLIOSIDOSES".
THE VOICE OF THE PATIENT REPORT FROM THE EXTERNALLY-LED PATIENT-FOCUSED DRUG DEVELOPMENT MEETING (EL-PFDD) WAS PUBLISHED ON THE FDA WEBSITE.
TEGA RECEIVED A SMALL BUSINESS INNOVATION RESEARCH (SBIR) GRANT BASED ON SEED FUNDING PROVIDED BY CURE GM1 TO CONTINUE THEIR ENZYME REPLACEMENT THERAPY STUDY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $533,720 | $521,967 | +0.0% |
| Expenses | $689,298 | $219,320 | +2.1% |
| Net Income | $-155,578 | $302,647 | -1.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| VANESSA RANGEL MILLER | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| KYLIE HARRISON | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DAVID LAW | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| BINGYUNE CHEN | DIRECTOR | 0.00 |
Director
|
$0 | $0 | $0 |
| RAFAEL ESCANDON | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| CHRISTINE M WAGGONER | CEO | 15.00 |
Officer
|
$0 | $0 | $0 |
| DAWN BLESSING | VICE PRESIDENT | 5.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $533,720 | $689,298 | $3,216,016 | $-155,578 |
| 2022 | $521,967 | $219,320 | $3,215,700 | $302,647 |
| 2021 | $549,261 | $142,807 | $3,273,591 | $406,454 |
| 2020 | $617,781 | $30,608 | $2,781,750 | $587,173 |
| 2019 | $373,224 | $79,883 | $2,194,622 | $293,341 |
| 2019 | $373,224 | $79,883 | $2,194,622 | $293,341 |
| 2018 | $373,562 | $125,916 | $1,901,236 | $247,646 |
Compare CURE GM1 INCORPORATED with other nonprofits in California and across the country.